Helicos BioSciences Corporation announced that Stephen J. Lombardi resigned as president and as a member of the board of directors.[break]
Mr. Lombardi joined Helicos in June 2006. Mr. Lombardi has more than 27 years of commercial biotechnology experience, as a researcher and in various business management and executive positions. Prior to joining Helicos, Mr. Lombardi was Senior Vice President at Affymetrix, serving in executive positions in Corporate Development, Product Development and Research and Corporate Marketing.
Before Affymetrix, Mr. Lombardi worked for 16 years at Applied Biosystems in various business roles, first as a marketing manager and later as a senior executive. From 1989 to 1998, Mr. Lombardi led the formation of the company's DNA sequencing and genetic analysis business, the products of which formed the technological basis of the worldwide Human Genome Project.
Mr. Lombardi was also involved in the formation of Celera within the broader Applera corporate structure. Prior to joining Applied Biosystems, Mr. Lombardi spent 8+ years as a nucleic acids chemist focused on the development of novel approaches to DNA synthesis. Mr. Lombardi earned his BA in Biology from Merrimack College.
The company appointed Ronald A. Lowy, the current chief executive officer, to serve as the President. Mr. Lowy has served as the Company’s Chief Executive Officer since December 2008 and as a member of its Board of Directors since November 2007.
From April 2007 to November 2007, Mr. Lowy served as a self - February 15, 2010, Helicos BioSciences Corporation announced that Stephen J. Lombardi resigned as president and as a member of the board of directors.
Article continues below
Mr. Lombardi joined Helicos in June 2006. Mr. Lombardi has more than 27 years of commercial biotechnology experience, as a researcher and in various business management and executive positions. Prior to joining Helicos, Mr. Lombardi was Senior Vice President at Affymetrix, serving in executive positions in Corporate Development, Product Development and Research and Corporate Marketing.
Before Affymetrix, Mr. Lombardi worked for 16 years at Applied Biosystems in various business roles, first as a marketing manager and later as a senior executive. From 1989 to 1998, Mr. Lombardi led the formation of the company's DNA sequencing and genetic analysis business, the products of which formed the technological basis of the worldwide Human Genome Project.
Mr. Lombardi was also involved in the formation of Celera within the broader Applera corporate structure. Prior to joining Applied Biosystems, Mr. Lombardi spent 8+ years as a nucleic acids chemist focused on the development of novel approaches to DNA synthesis. Mr. Lombardi earned his BA in Biology from Merrimack College.
The company appointed Ronald A. Lowy, the current chief executive officer, to serve as the President. Mr. Lowy has served as the Company’s Chief Executive Officer since December 2008 and as a member of its Board of Directors since November 2007.
From April 2007 to November 2007, Mr. Lowy served as a self-employed consultant. Mr. Lowy was the President and CEO of Fisher BioSciences, part of Thermo Fisher Scientific, from November 2004 until April 2007. ■
LATEST MOVES FROM Helicos BioSciences Corporation announced that Stephen J. Lombardi resigned as president and as a member of the board of directors.[break]
Mr. Lombardi joined Helicos in June 2006. Mr. Lombardi has more than 27 years of commercial biotechnology experience, as a researcher and in